I agree that this site is using cookies. You can find further informations
here
.
X
Login
My folder (
0
)
Home
About us
Home About us
Our history
Profile
Press & public relations
Friends
The library in figures
Exhibitions
Projects
Training, internships, careers
Films
Services & Information
Home Services & Information
Lending and interlibrary loans
Returns and renewals
Training and library tours
My Account
Library cards
New to the library?
Download Information
Opening hours
Learning spaces
PC, WLAN, copy, scan and print
Catalogs and collections
Home Catalogs and Collections
Rare books and manuscripts
Digital collections
Subject Areas
Our sites
Home Our sites
Central Library
Law Library (Juridicum)
BB Business and Economics (BB11)
BB Physics and Electrical Engineering
TB Engineering and Social Sciences
TB Economics and Nautical Sciences
TB Music
TB Art & Design
TB Bremerhaven
Contact the library
Home Contact the library
Staff Directory
Open access & publishing
Home Open access & publishing
Reference management: Citavi & RefWorks
Publishing documents
Open Access in Bremen
Show Desktop-Version
Toggle navigation
Abruzzese, E.
209
results:
Search for persons
X
Format
Online (209)
Mediatypes
Articles (Online) (39)
OpenAccess-fulltext (170)
Languages
english (188)
italian (9)
Sorted by: Relevance
Sorted by: Year
?
1
Ruxolitinib Adherence in Myelofibrosis and Polycythemia Ver..:
Palandri, F.
;
Auteri, G.
;
Abruzzese, E.
...
Annals of Hematology. 103 (2024) 6 - p. 1931-1940 , 2024
Link:
https://doi.org/10.1007/..
?
2
Treatment discontinuation following low-dose TKIs in 248 ch..:
Iurlo, A.
;
Cattaneo, D.
;
Consonni, D.
...
Frontiers in Pharmacology. 14 (2023) - p. , 2023
Link:
https://doi.org/10.3389/..
?
3
P707: DOSE MODIFICATION DYNAMICS OF PONATINIB IN PATIENTS W..:
Apperley, J.
;
Kantarjian, H.
;
Deininger, M.
...
HemaSphere. 6 (2022) - p. 602-603 , 2022
Link:
https://doi.org/10.1097/..
?
4
S111: REPEATED INFUSIONS OF ESCALATING DOSES OF EXPANDED AN..:
Torelli, G. F.
;
Chiaretti, S.
;
Peragine, N.
...
HemaSphere. 6 (2022) - p. 12-13 , 2022
Link:
https://doi.org/10.1097/..
?
5
P1706: CLINICAL UTILITY OF ONLINE MONITORING OF PATIENT-REP..:
Efficace, F.
;
Cottone, F.
;
Yanez, B.
...
HemaSphere. 6 (2022) - p. 1587-1588 , 2022
Link:
https://doi.org/10.1097/..
?
6
S156: INTERNATIONAL, PROSPECTIVE STUDY COMPARING NILOTINIB ..:
Pane, F.
;
Castagnetti, F.
;
Luciano, L.
...
HemaSphere. 6 (2022) - p. 57-58 , 2022
Link:
https://doi.org/10.1097/..
?
7
P698: BOSUTINIB DOSE OPTIMIZATION IN THE SECOND-LINE TREATM..:
Castagnetti, F.
;
Bocchia, M.
;
Abruzzese, E.
...
HemaSphere. 6 (2022) - p. 593-594 , 2022
Link:
https://doi.org/10.1097/..
?
8
P712: ASCIMINIB ITALIAN MANAGED ACCESS PROGRAM: EFFICACY PR..:
Breccia, M.
;
Russo Rossi, A. V.
;
Martino, B.
...
HemaSphere. 6 (2022) - p. 607-608 , 2022
Link:
https://doi.org/10.1097/..
?
9
Bosutinib for pretreated patients with chronic phase chroni..:
Hochhaus, Andreas
;
Gambacorti-Passerini, Carlo
;
Abboud, Camille
...
Leukemia. 34 (2020) 8 - p. 2125-2137 , 2020
Link:
https://doi.org/10.1038/..
?
10
Clinical impact of low-burden BCR-ABL1 mutations detectable..:
Soverini, S
;
De Benedittis, C
;
Papayannidis, C
...
Leukemia. 30 (2016) 7 - p. 1615-1619 , 2016
Link:
https://doi.org/10.1038/..
?
11
Managing chronic myeloid leukaemia in the elderly with inte..:
Russo, D
;
Malagola, M
;
Skert, C
...
Blood Cancer Journal. 5 (2015) 9 - p. e347-e347 , 2015
Link:
https://doi.org/10.1038/..
?
12
Severe Peripheral Arterial Disease During Nilotinib Therapy:
Le Coutre, P.
;
Rea, D.
;
Abruzzese, E.
...
JNCI Journal of the National Cancer Institute. 103 (2011) 17 - p. 1347-1348 , 2011
Link:
https://doi.org/10.1093/..
?
13
Conversion to Rapamycin Immunosuppression for Malignancy Af..:
Iaria, G.
;
Anselmo, A.
;
De Luca, L.
...
Transplantation Proceedings. 39 (2007) 6 - p. 2036-2037 , 2007
Link:
https://doi.org/10.1016/..
?
14
A phase-II trial of all trans retinoic acid and low-dose cy..:
Venditti, A.
;
Tamburini, A.
;
Buccisano, F.
...
Annals of Hematology. 79 (2000) 3 - p. 138-142 , 2000
Link:
https://doi.org/10.1007/..
?
15
Progression of a myelodysplastic syndrome to pre-B acute ly..:
Abruzzese, E.
;
Buss, D.
;
Rainer, R.
..
Annals of Hematology. 73 (1996) 1 - p. 35-38 , 1996
Link:
https://doi.org/10.1007/..
1-15